ATEX vs GRPN

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of just 2/9, signaling significant operational and profitability concerns. Despite a low P/E of 4.72 and a Graham Number of $38.17 suggesting undervaluation, the negative forward P/E, erratic earnings, and extremely high reported profit margin of 1614% indicate unreliable profitability metrics. The stock trades well below analyst target of $55.33, but weak revenue growth, negative operating margins, and bearish insider activity raise sustainability concerns. Technical trend at 0/100 and declining long-term price performance further support a cautious outlook.

GRPN exhibits severe financial distress, highlighted by a weak Piotroski F-Score of 2/9 and a negative Price-to-Book ratio of -11.35, indicating negative shareholder equity. While the company maintains a high gross margin (90.79%) and a low forward P/E (6.74), these are overshadowed by stagnant revenue growth (1.80%) and a net profit margin of -16.76%. Liquidity is tight with a current ratio of 0.97, and the technical trend is completely bearish. Despite optimistic analyst price targets, the fundamental health indicators suggest a high risk of insolvency or further devaluation.